DL-Threonine

DL-Threonine is a threonine amino acid in which the stereogenic center is present as a racemic mixture (DL), featuring a primary amino group and a carboxylic acid functionality alongside a secondary alcohol on the side chain. The molecule's polar hydroxyl and carboxyl groups enable strong hydrogen-bonding interactions and aqueous solubility, while the amino group participates readily in salt formation and peptide-bond formation after appropriate activation. As an amino acid with a chiral backbone in the threonine family, DL-Threonine serves as a practical starting material for stereochemical studies and for building chiral derivatives after resolution or stereoselective transformations. The side-chain hydroxyl can be protected, converted, or functionalized to support downstream synthesis of peptide building blocks, amino acid derivatives, and process-ready intermediates.

1. Peptide Synthesis

DL-Threonine is used in peptide coupling workflows where the amino acid provides the threonine residue for C-N bond formation and incorporation into peptide chains. The amino and carboxyl groups enable standard peptide-bond strategies after conversion to an activated carboxyl derivative, while the side-chain hydroxyl can be protected to prevent competing reactions during N- or C-terminal assembly. Racemic composition makes DL-Threonine suitable for generating mixed stereochemical peptide libraries, reference materials, or method development when stereopurity is not the primary requirement. Downstream, threonine-containing peptides and peptide fragments prepared from DL-Threonine can be used for mapping coupling selectivity, evaluating protecting-group stability, and preparing analogs for biochemical assays.

2. Amino Acid Derivatization

DL-Threonine is applied in amino acid derivatization chemistry to access functionalized threonine derivatives through transformations of the amino, carboxyl, and side-chain hydroxyl groups. The alcohol group can be esterified, etherified, or oxidized to yield intermediates that support further functional group interconversions, while the carboxyl moiety can be converted into amides, esters, or activated intermediates for downstream coupling. Racemic stereochemistry can be leveraged to produce non-stereospecific derivatives for analytical standards, method screening, or bulk intermediate manufacture where enantiomer separation is deferred. Resulting products include protected or functionalized threonine analogs that feed into peptide construction, chiral auxiliary studies, and synthetic organic chemistry routes requiring a hydroxyl-bearing amino acid scaffold.

3. Chiral Resolution Studies

DL-Threonine is suitable for chiral synthesis and stereochemical research because its racemic mixture can be subjected to resolution strategies that generate enantiomer-enriched threonine derivatives. The presence of both an amino group and a carboxylic acid allows formation of diastereomeric salts or complexes with chiral acids or chiral derivatizing agents, while the side-chain hydroxyl provides additional stereochemical discrimination through hydrogen-bonding interactions. Resolved fractions can then be carried forward into protected amino acid synthesis, peptide building block preparation, or stereodefined derivatization for structure-function investigations. Downstream use includes preparing enantiopure threonine derivatives for stereochemical method validation, chiral intermediate supply, and racemate-to-enantiomer conversion studies in process chemistry.

4. Pharmaceutical Intermediate Preparation

DL-Threonine is employed as an amino acid-based intermediate in pharmaceutical and fine-chemical manufacturing contexts where polar functional groups support controlled derivatization and downstream assembly. The amino acid's carboxyl and hydroxyl functionalities can be converted into protected forms or activated derivatives that participate in coupling steps toward peptidomimetic scaffolds, heteroatom-containing side chains, or solubilizing motifs. Racemic material can serve as a feedstock for intermediate families where stereochemistry is introduced later through selective transformations or resolution in the synthetic sequence. Resulting intermediates can be used to build larger molecular architectures with defined functional group patterns relevant to medicinal chemistry and industrial intermediate supply chains.

5. Analytical Research Standards

DL-Threonine is used in analytical research as a reference compound for amino acid profiling, derivatization method development, and stereochemical characterization workflows. The combination of amino, carboxyl, and hydroxyl groups enables robust detection after derivatization for chromatographic or spectrometric analysis, and the racemic nature supports calibration of enantiomer separation methods. Side-chain hydroxyl reactivity supports formation of derivative classes that can be used to evaluate derivatization completeness, stability, and method reproducibility across amino acid families. Downstream, DL-Threonine-derived standards and derivatives can support quality control of peptide hydrolysates, monitoring of amino acid transformations, and verification of stereochemical outcomes in synthetic process development.

1. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

2. High fat diet and GLP-1 drugs induce pancreatic injury in mice

3. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

4. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

5. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance